Metastatic Hormone Refractory Prostate Cancer Active Not Recruiting Phase 1 / 2 Trials for Cabazitaxel (DB06772)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Active Not Recruiting1 / 2 IdentifierTitlePurposeDrugs
NCT02522715Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerTreatment
NCT01505868Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate CancerTreatment